Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. (ACRV) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 81 transactions totaling $67.5M, demonstrating a bullish sentiment with $67.3M in net insider flow. The most recent transaction on Jan 13, 2026 involved a purchase of 10,000 shares valued at $17.2K.
ACRV Insider Activity Summary
Who Is Buying ACRV Stock?
No significant insider buying has been recorded for ACRV in the recent period.
Who Is Selling ACRV Stock?
No significant insider selling has been recorded for ACRV in the recent period.
Is Acrivon Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ACRV is bullish with an Insider Alignment Score of 100/100 and a net flow of $67.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ACRV Frequently Asked Questions
Understanding ACRV Insider Activity
Insider trading at Acrivon Therapeutics, Inc. (ACRV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading ACRV stock, having executed 81 transactions in the past 90 days. The most active insider is Capital Healthcare Fund Lp Ra (Executive), who has made 4 transactions totaling $72.4M.
Related Tools
Track Acrivon Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ACRV file new Form 4 transactions